Erythropoietin in the critically ill - is it more than just blood?
Erythropoietin (EPO) has been in clinical use for the treatment of anemia for over 15 years. Recently it has been demonstrated that EPO has actions other than stimulating the bone marrow. It has been suggested that due to its tissue protecting effect, EPO may be effective in improving outcome in the critically ill.
Dartmouth Medical School, Lebanon, New Hampshire, USA. Howard.L.Corwin@hitchcock.org
Howard L
HL
Corwin
D017209:Apoptosis / Q000187:drug effects / Q000276:immunology*; D003422:Critical Care / Q000379:methods*; D016638:Critical Illness; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D011994:Recombinant Proteins; D016896:Treatment Outcome
D011994:Recombinant Proteins; D004921:Erythropoietin